
  
    
      
        Background_NNP
        Congenital_NNP fibrosis_NNS of_IN the_DT extraocular_NN muscles_NNS (_( CFEOM_NNP )_)
        and_CC Duane_NNP syndrome_NN (_( DS_NNP )_) are_VBP complex_JJ strabismus_JJ disorders_NNS
        that_IN present_JJ with_IN congenital_NN restrictive_JJ ophthalmoplegia_NN
        with_IN or_CC without_IN ptosis_NNS ._. These_DT disorders_NNS were_VBD traditionally_RB
        believed_VBN to_TO reflect_VB primary_JJ structural_JJ extraocular_NN muscle_NN
        (_( EOM_NNP )_) anomalies_NNS and_CC have_VBP been_VBN referred_VBN to_TO as_IN '_POS congenital_NN
        fibrosis_NNS syndromes_NNS '_POS [_NN 1_CD ]_NN ._. Neuropathology_NNP studies_NNS of_IN DS_NNP [_NN
        2_CD 3_CD ]_NN and_CC one_CD form_NN of_IN CFEOM_NNP (_( CFEOM_NNP 1_LS )_) [_NN 4_CD ]_NN ,_, and_CC the_DT
        identification_NN of_IN 
        ARIX_NNP as_IN the_DT gene_NN mutated_VBN in_IN a_DT second_JJ
        form_NN of_IN CFEOM_NNP (_( CFEOM_NNP 2_LS )_) [_NN 5_CD ]_NN ,_, however_RB ,_, support_NN our_PRP$
        hypothesis_NNS that_IN CFEOM_NNP results_NNS from_IN maldevelopment_NN of_IN the_DT
        oculomotor_NN (_( nIII_NN )_) and_CC /_NN or_CC trochlear_NN (_( nIV_NN )_) nuclei_NN and_CC DS_NNP
        results_NNS from_IN maldevelopment_NN of_IN the_DT abducens_NNS (_( nVI_NN )_) nucleus_NN ._.
        The_DT continued_VBN definition_NN of_IN these_DT phenotypes_NNS and_CC
        identification_NN of_IN the_DT underlying_VBG disease_NN genes_NNS will_MD assist_VB
        clinical_JJ diagnostics_NNS and_CC lead_VB to_TO a_DT better_JJR understanding_NN of_IN
        the_DT unique_JJ developmental_NN features_NNS of_IN the_DT oculomotor_NN lower_JJR
        motor_NN neuron_NN unit_NN ._.
        Although_IN several_JJ distinct_JJ CFEOM_NNP phenotypes_NNS have_VBP been_VBN
        defined_VBN [_NN 6_CD 7_CD 8_CD ]_NN ,_, each_DT likely_JJ resulting_VBG from_IN
        maldevelopment_NN of_IN a_DT unique_JJ combination_NN of_IN alpha_NN motor_NN
        neurons_NNS in_IN nIII_NN and_CC /_NN or_CC nIV_NN ,_, most_JJS reports_NNS of_IN CFEOM_NNP families_NNS
        describe_VBP a_DT stereotypical_JJ clinical_JJ phenotype_NN ._. The_DT affected_VBN
        members_NNS of_IN these_DT pedigrees_NNS are_VBP born_VBN with_IN bilateral_JJ ptosis_NNS
        and_CC restrictive_JJ ophthalmoplegia_NN ._. The_DT primary_JJ vertical_JJ
        position_NN of_IN each_DT eye_NN is_VBZ downward_JJ and_CC cannot_NN be_VB elevated_VBD
        above_IN the_DT midline_NN ._. On_IN forced_VBN duction_NN testing_NN there_EX is_VBZ
        resistance_NN to_TO passive_JJ movement_NN of_IN the_DT globe_NN ._. Although_IN the_DT
        primary_JJ position_NN of_IN both_DT eyes_NNS is_VBZ infraducted_JJ ,_, there_EX is_VBZ
        variability_NN in_IN the_DT secondary_JJ position_NN of_IN each_DT eye_NN (_( i_NNP ._. e_SYM ._.
        exotropic_JJ ,_, esotropic_JJ ,_, or_CC neutral_JJ )_) ,_, and_CC the_DT degree_NN of_IN
        residual_JJ horizontal_NN movement_NN within_IN the_DT lower_JJR quadrants_NNS
        (_( full_JJ to_TO completely_RB restricted_VBN )_) ._. This_DT CFEOM_NNP phenotype_NN was_VBD
        first_RB described_VBD in_IN the_DT medical_JJ literature_NN in_IN 1840_CD [_NN 9_CD ]_NN and_CC
        was_VBD recognized_VBN to_TO occur_VB as_IN a_DT familial_NN trait_NN in_IN 1879_CD [_NN 10_CD ]_NN
        ._. Subsequently_NNP ,_, families_NNS segregating_VBG this_DT phenotype_NN have_VBP
        been_VBN published_VBN under_IN myriad_JJ names_NNS [_NN 1_CD 4_CD 6_CD 11_CD 12_CD 13_CD 14_CD 15_CD 16_CD
        17_CD 18_CD 19_CD 20_CD 21_CD ]_NN ._. We_PRP now_RB refer_VBP to_TO individuals_NNS with_IN this_DT
        phenotype_NN as_RB having_VBG "_'' classic_JJ CFEOM_NNP "_'' and_CC to_TO families_NNS in_IN
        which_WDT all_DT affected_VBN members_NNS have_VBP this_DT phenotype_NN as_IN "_'' CFEOM_NNP 1_CD
        pedigrees_NNS "_'' ._. We_PRP previously_RB mapped_VBN a_DT CFEOM_NNP 1_CD locus_JJ ,_, referred_VBD
        to_TO as_IN 
        FEOM_NNP 1_CD ,_, to_TO a_DT ≤_NN 3_CD cM_NN region_NN spanning_VBG
        the_DT centromere_NN of_IN chromosome_NN 12_CD ,_, flanked_JJ by_IN 
        D_NNP 12_CD S_NNP 1584_CD (_( AFM_NNP 136_CD xf_NN 6_CD )_) on_IN the_DT p-arm_JJ and_CC
        
        D_NNP 12_CD S_NNP 1668_CD (_( AFMb_NNP 320_CD wd_NN 9_CD )_) on_IN the_DT q-arm_JJ [_NN
        6_CD 15_CD ]_NN ._.
        In_IN addition_NN to_TO families_NNS with_IN CFEOM_NNP 1_CD ,_, we_PRP have_VBP identified_VBN
        several_JJ less_RBR common_JJ familial_NN CFEOM_NNP phenotypes_NNS (_( CFEOM_NNP 2_CD and_CC
        CFEOM_NNP 3_LS )_) ._. These_DT phenotypes_NNS are_VBP classified_VBN as_IN CFEOM_NNP based_VBN on_IN
        the_DT presence_NN of_IN affected_VBN members_NNS with_IN congenital_NN
        restrictive_JJ ophthalmoplegia_NN affecting_VBG extraocular_NN muscles_NNS
        in_IN the_DT nIII_NN /_NN nIV_NN distribution_NN ._. By_IN definition_NN ,_, however_RB ,_, one_CD
        or_CC more_RBR affected_JJ family_NN members_NNS do_VBP not_RB have_VB the_DT classic_JJ
        CFEOM_NNP phenotype_NN ._. In_IN families_NNS with_IN CFEOM_NNP 2_CD ,_, the_DT eyes_NNS of_IN
        affected_VBN family_NN members_NNS are_VBP fixed_VBN in_IN an_DT exotropic_JJ ,_, or_CC
        outward_RB ,_, position_NN ._. Thus_RB far_RB ,_, this_DT phenotype_NN segregates_NNS as_IN
        an_DT autosomal_NN recessive_JJ trait_NN and_CC maps_NNS to_TO the_DT 
        FEOM_NNP 2_CD locus_JJ on_IN chromosome_NN 11_CD q_NN 13_CD [_NN 8_CD ]_NN
        ,_, and_CC affected_VBD individuals_NNS carry_VBP homozygous_JJ mutations_NNS in_IN 
        ARIX_NNP [_NN 5_CD ]_NN ._. 
        ARIX_NNP encodes_NNS a_DT homeodomain_NN
        transcription_NN factor_NN required_VBN for_IN nIII_NN and_CC nIV_NN development_NN
        in_IN mice_NNS and_CC zebrafish_NN [_NN 22_CD 23_CD ]_NN ._. In_IN families_NNS with_IN CFEOM_NNP 3_CD ,_,
        the_DT CFEOM_NNP phenotype_NN is_VBZ variably_RB expressed_VBN ._. Some_DT affected_VBN
        members_NNS have_VBP classic_JJ CFEOM_NNP ._. Others_NNS ,_, however_RB ,_, are_VBP
        unilaterally_RB affected_VBN ,_, the_DT primary_JJ position_NN of_IN the_DT eye_NN is_VBZ
        orthotropic_JJ rather_RB than_IN infraducted_JJ ,_, and_CC /_NN or_CC the_DT eye_NN can_MD be_VB
        raised_VBN into_IN the_DT upper_JJ quadrants_NNS ._. Thus_RB far_RB ,_, this_DT phenotype_NN
        segregates_NNS as_IN an_DT autosomal_NN dominant_JJ trait_NN and_CC maps_NNS to_TO
        either_CC 
        FEOM_NNP 3_CD on_IN 16_CD qter_NN [_NN 7_CD ]_NN or_CC to_TO 
        FEOM_NNP 1_CD [_NN 24_CD ]_NN ._.
        In_IN our_PRP$ attempt_NN to_TO understand_VB phenotype-genotype_JJ
        correlations_NNS between_IN specific_JJ CFEOM_NNP phenotypes_NNS and_CC 
        FEOM_NNP loci_NN ,_, we_PRP noted_VBD that_IN the_DT CFEOM_NNP 1_CD
        phenotype_NN in_IN all_DT pedigrees_NNS reported_VBD to_TO date_NN maps_NNS to_TO the_DT 
        FEOM_NNP 1_CD locus_JJ ._. To_TO determine_VB if_IN CFEOM_NNP 1_CD
        is_VBZ indeed_RB genetically_RB homogeneous_JJ ,_, we_PRP identified_VBD all_DT
        unpublished_JJ CFEOM_NNP 1_CD pedigrees_NNS in_IN our_PRP$ database_NN ,_, analyzed_VBD them_PRP
        for_IN linkage_NN to_TO the_DT 
        FEOM_NNP loci_NN ,_, and_CC found_VBD that_IN most_JJS but_CC
        not_RB all_DT were_VBD consistent_JJ with_IN linkage_NN to_TO 
        FEOM_NNP 1_CD ._. The_DT two_CD small_JJ pedigrees_NNS not_RB
        linked_VBN to_TO 
        FEOM_NNP 1_CD were_VBD consistent_JJ with_IN linkage_NN to_TO
        
        FEOM_NNP 3_CD ._. In_IN addition_NN ,_, to_TO further_VB define_VB
        the_DT spectrum_NN of_IN human_JJ 
        ARIX_NNP mutations_NNS ,_, we_PRP identified_VBD all_DT
        CFEOM_NNP 1_CD families_NNS consistent_JJ with_IN linkage_NN to_TO 
        FEOM_NNP 2_CD or_CC sporadic_JJ individuals_NNS with_IN
        classic_JJ CFEOM_NNP and_CC determined_VBN that_DT none_NN harbored_JJ mutations_NNS
        in_IN the_DT 
        ARIX_NNP gene_NN ._.
      
      
        Results_NNS
        
          Linkage_NNP to_TO FEOM_NNP 1_CD
          Genetic_JJ analyses_NNS of_IN the_DT two_CD largest_JJS families_NNS (_( BJ_NNP ,_, CZ_NNP )_)
          established_VBN linkage_NN of_IN their_PRP$ phenotype_NN to_TO the_DT 
          FEOM_NNP 1_CD locus_JJ (_( Fig_NNP ._. 1_LS ,_, Table_NNP 1_CD &_CC
          see_VB Additional_JJ File_NNP 1_LS )_) ._. Maximum_NNP lod_NN scores_NNS of_IN 3_CD ._. 01_CD were_VBD
          obtained_VBN at_IN a_DT theta_NN value_NN of_IN zero_CD for_IN the_DT fully_RB
          informative_JJ markers_NNS 
          D_NNP 12_CD S_NNP 59_CD and_CC 
          D_NNP 12_CD S_NNP 1048_CD in_IN family_NN BJ_NNP ,_, and_CC the_DT
          fully_RB informative_JJ markers_NNS 
          D_NNP 12_CD S_NNP 1648_CD ,_, D_NNP 12_CD S_NNP 345_CD ,_, and_CC 
          D_NNP 12_CD S_NNP 59_CD in_IN family_NN CZ_NNP ._.
          Linkage_NNP to_TO 
          FEOM_NNP 1_CD was_VBD ruled_VBN out_IN in_IN family_NN BT_NNP
          (_( see_VB Additional_JJ file_NN 1_LS )_) ._. A_DT lod_NN score_NN of_IN -_: 2_CD was_VBD obtained_VBN
          at_IN a_DT theta_NN value_NN of_IN 0_CD ._. 04_CD for_IN the_DT fully_RB informative_JJ
          markers_NNS 
          D_NNP 12_CD S_NNP 1621_CD ,_, D_NNP 12_CD S_NNP 59_CD and_CC 
          D_NNP 12_CD S_NNP 1668_CD ._. The_DT 
          FEOM_NNP 1_CD critical_JJ region_NN is_VBZ ≤_NN 3_CD cM_NN ,_,
          and_CC a_DT theta_NN of_IN 0_CD ._. 04_CD corresponds_NNS to_TO a_DT genetic_JJ distance_NN of_IN
          approximately_RB 4_CD cM_NN ,_, thus_RB eliminating_VBG linkage_NN of_IN this_DT
          family_NN 's_POS CFEOM_NNP disease_NN gene_NN to_TO the_DT entire_JJ 
          FEOM_NNP 1_CD critical_JJ region_NN ._. Exclusion_NNP of_IN
          linkage_NN to_TO the_DT 
          FEOM_NNP 1_CD locus_JJ is_VBZ further_RBR supported_VBN by_IN
          haplotype_NN analysis_NN of_IN this_DT family_NN (_( Fig_NNP ._. 2_LS c_SYM )_) ._. The_DT affected_VBN
          sister_NN and_CC brother_NN inherit_VBP different_JJ 
          FEOM_NNP 1_CD haplotypes_NNS from_IN their_PRP$
          affected_VBN mother_NN ,_, and_CC the_DT brother_NN 's_POS affected_VBN daughter_NN
          inherits_VBZ her_PRP$ unaffected_JJ paternal_NN grandfather_NN 's_POS 
          FEOM_NNP 1_CD haplotype_NN ,_, thus_RB proving_VBG
          non-association_JJ between_IN the_DT 
          FEOM_NNP 1_CD haplotype_NN and_CC the_DT disease_NN
          phenotype_NN ._.
          The_DT eight_CD remaining_VBG CFEOM_NNP pedigrees_NNS were_VBD too_RB small_JJ to_TO
          produce_VB statistically_RB significant_JJ lod_NN scores_NNS ;_: however_RB ,_,
          seven_CD of_IN the_DT eight_CD families_NNS displayed_VBD haplotype_NN and_CC

          linkage_NN data_NNS consistent_JJ with_IN linkage_NN to_TO the_DT 
          FEOM_NNP 1_CD locus_JJ (_( Fig_NNP ._. 1_LS ,_, see_VBP Additional_JJ
          File_NNP 1_LS )_) ._. Genetic_NNP and_CC haplotype_NN analysis_NN of_IN all_DT nine_CD
          families_NNS consistent_JJ with_IN linkage_NN to_TO the_DT 
          FEOM_NNP 1_CD locus_JJ did_VBD not_RB reveal_VB any_DT
          recombination_NN events_NNS within_IN the_DT previously_RB defined_VBN 
          FEOM_NNP 1_CD critical_JJ region_NN ._.
          The_DT smallest_JJS family_NN ,_, K_NNP ,_, revealed_VBD haplotype_NN and_CC linkage_NN
          data_NNS that_WDT was_VBD inconsistent_JJ with_IN linkage_NN to_TO the_DT 
          FEOM_NNP 1_CD locus_JJ (_( Fig_NNP ._. 2_LS a_DT ,_, see_VB
          Additional_JJ File_NNP 1_LS )_) ._. A_DT lod_NN score_NN of_IN -_: 2_CD was_VBD obtained_VBN at_IN a_DT
          theta_NN value_NN of_IN 0_CD ._. 002_CD for_IN the_DT only_RB two_CD informative_JJ
          markers_NNS ,_, 
          D_NNP 12_CD S_NNP 59_CD and_CC 
          D_NNP 12_CD S_NNP 1090_CD ._. These_DT theta_NN values_NNS
          eliminate_VBP linkage_NN to_TO only_RB 0_CD ._. 8_CD cM_NN of_IN the_DT <_NN 3_CD cM_NN 
          FEOM_NNP 1_CD critical_JJ region_NN and_CC ,_,
          therefore_RB ,_, this_DT locus_JJ cannot_NN be_VB formally_RB ruled_VBN out_RP ._.
          Nevertheless_RB ,_, the_DT minimum_JJ number_NN of_IN recombination_NN events_NNS
          in_IN this_DT family_NN occurs_VBZ only_RB if_IN the_DT affected_VBN son_NN and_CC
          daughter_NN inherit_VBP different_JJ 
          FEOM_NNP 1_CD haplotypes_NNS from_IN their_PRP$
          affected_VBN mother_NN ,_, thus_RB strongly_RB suggesting_VBG that_IN the_DT
          disease_NN gene_NN in_IN this_DT family_NN does_VBZ not_RB map_VB to_TO the_DT
          chromosome_NN 12_CD locus_JJ ._.
          Genetic_JJ heterogeneity_NN was_VBD tested_VBN taking_VBG into_IN account_NN
          the_DT eleven_CD new_JJ families_NNS ._. Admixture_NNP analysis_NN of_IN the_DT
          two-point_JJ data_NN with_IN the_DT HOMOG_NNP program_NN showed_VBD evidence_NN for_IN
          linkage_NN to_TO 
          FEOM_NNP 1_CD with_IN heterogeneity_NN for_IN both_DT
          markers_NNS tested_VBN (_( 
          D_NNP 12_CD S_NNP 345_CD and_CC 
          D_NNP 12_CD S_NNP 1048_CD )_) ._. Chi-squares_NNP of_IN 34_CD ._. 601_CD
          and_CC 40_CD ._. 377_CD were_VBD obtained_VBN for_IN 
          D_NNP 12_CD S_NNP 345_CD and_CC 
          D_NNP 12_CD S_NNP 1048_CD respectively_RB which_WDT
          resulted_VBD in_IN significant_JJ likelihood_NN ratios_NNS of_IN 3_CD ._. 26_CD ×_NN 10_CD
          7_CD and_CC 5_CD ._. 86_CD ×_NN 10_CD 8_CD ._. Alpha_NNP (_( the_DT proportion_NN of_IN linked_VBN
          families_NNS )_) was_VBD 0_CD ._. 90_CD ._.
        
        
          Linkage_NNP to_TO FEOM_NNP 3_CD
          All_DT families_NNS except_IN BJ_NNP and_CC CZ_NNP were_VBD analyzed_VBN for_IN
          linkage_NN to_TO the_DT 5_CD ._. 6_CD cM_NN 
          FEOM_NNP 3_CD locus_JJ flanked_JJ by_IN 
          D_NNP 16_CD S_NNP 486_CD and_CC 16_CD qter_NN ._. Of_IN the_DT seven_CD
          small_JJ families_NNS consistent_JJ with_IN linkage_NN to_TO 
          FEOM_NNP 1_CD ,_, only_RB the_DT largest_JJS (_( AG_NNP )_) can_MD be_VB
          definitively_RB excluded_VBN from_IN linkage_NN to_TO 
          FEOM_NNP 3_CD (_( see_VB Additional_JJ File_NNP 2_LS )_) ._. Five_CD
          of_IN the_DT remaining_VBG families_NNS (_( AJ_NNP ,_, AH_NNP ,_, T_NN ,_, BC_NNP ,_, CT_NNP )_) showed_VBD
          haplotype_NN data_NNS inconsistent_JJ with_IN linkage_NN to_TO 
          FEOM_NNP 3_CD ,_, but_CC the_DT theta_NN values_NNS
          obtained_VBN at_IN lod_NN scores_NNS of_IN -_: 2_CD were_VBD insufficient_JJ to_TO rule_VB
          out_RP the_DT entire_JJ 
          FEOM_NNP 3_CD critical_JJ region_NN ._.
          The_DT two_CD families_NNS whose_WP$ phenotype_NN did_VBD not_RB map_VB to_TO 
          FEOM_NNP 1_CD (_( K_NNP ,_, BT_NNP )_) had_VBD haplotype_NN and_CC
          linkage_NN data_NNS consistent_JJ with_IN linkage_NN to_TO 
          FEOM_NNP 3_CD (_( Fig_NNP ._. 2_LS b_SYM &_CC 2_CD d_SYM ,_, see_VB
          Additional_JJ File_NNP 2_LS )_) ._. In_IN addition_NN ,_, one_CD of_IN the_DT small_JJ
          families_NNS consistent_JJ with_IN linkage_NN to_TO the_DT 
          FEOM_NNP 1_CD locus_JJ (_( E_NNP )_) had_VBD haplotype_NN and_CC
          linkage_NN data_NNS that_WDT was_VBD also_RB consistent_JJ with_IN linkage_NN to_TO the_DT
          
          FEOM_NNP 3_CD locus_JJ (_( see_VB Additional_JJ File_NNP
          2_LS )_) ._.
        
        
          Linkage_NNP to_TO FEOM_NNP 2_CD
          All_DT families_NNS whose_WP$ phenotype_NN was_VBD not_RB linked_VBN to_TO 
          FEOM_NNP 1_CD or_CC 
          FEOM_NNP 3_CD were_VBD tested_VBN for_IN linkage_NN to_TO 
          FEOM_NNP 2_CD ._. Assuming_VBG autosomal_NN dominant_JJ
          inheritance_NN with_IN complete_JJ penetrance_NN ,_, two_CD families_NNS (_( AG_NNP ,_,
          E_NNP )_) are_VBP not_RB linked_VBN and_CC five_CD families_NNS are_VBP inconsistent_JJ with_IN
          linkage_NN (_( AJ_NNP ,_, AH_NNP ,_, T_NN ,_, CT_NNP ,_, BT_NNP )_) to_TO the_DT 
          FEOM_NNP 2_CD locus_JJ (_( see_VB Additional_JJ File_NNP
          3_LS )_) ._. Family_NNP BC_NNP is_VBZ consistent_JJ with_IN linkage_NN to_TO both_DT the_DT 
          FEOM_NNP 2_CD and_CC 
          FEOM_NNP 1_CD loci_NN (_( maximum_NN lod_NN score_NN 0_CD ._. 3_CD
          at_IN both_DT loci_NN )_) ,_, and_CC family_NN K_NNP is_VBZ consistent_JJ with_IN linkage_NN to_TO
          both_DT the_DT 
          FEOM_NNP 2_CD and_CC 
          FEOM_NNP 3_CD loci_NN (_( maximum_NN lod_NN score_NN 0_CD ._. 3_CD
          at_IN both_DT loci_NN )_) ._.
        
        
          ARIXmutation_NNP analysis_NN
          Genomic_NNP DNA_NNP samples_NNS from_IN affected_VBN member_NN of_IN pedigree_NN
          BC_NNP and_CC K_NNP and_CC 5_CD sporadic_JJ individuals_NNS with_IN classic_JJ CFEOM_NNP
          were_VBD used_VBN as_IN templates_NNS to_TO sequence_NN the_DT three_CD 
          ARIX_NNP exons_NNS and_CC flanking_VBG introns_NNS ._. No_DT
          mutations_NNS were_VBD identified_VBN ._.
        
      
      
        Discussion_NNP
        We_PRP have_VBP established_VBN clinical_JJ criteria_NNS for_IN classic_JJ CFEOM_NNP
        and_CC CFEOM_NNP 1_CD ,_, and_CC have_VBP identified_VBN 5_CD sporadic_JJ individuals_NNS with_IN
        classic_JJ CFEOM_NNP and_CC 20_CD pedigrees_NNS with_IN CFEOM_NNP 1_CD ._. Of_IN these_DT 20_CD
        pedigrees_NNS ,_, 18_CD are_VBP linked_VBN ,_, or_CC consistent_JJ with_IN linkage_NN ,_, to_TO
        the_DT 
        FEOM_NNP 1_CD locus_JJ ._. Two_CD small_JJ CFEOM_NNP 1_CD
        pedigrees_NNS are_VBP not_RB consistent_JJ with_IN linkage_NN ,_, however_RB ,_,
        establishing_VBG that_IN CFEOM_NNP 1_CD is_VBZ genetically_RB heterogeneous_JJ ._.
        Eleven_CD of_IN the_DT 20_CD pedigrees_NNS are_VBP large_JJ enough_RB to_TO establish_VB
        linkage_NN to_TO a_DT specific_JJ locus_JJ ;_: we_PRP previously_RB reported_VBD that_IN
        the_DT CFEOM_NNP 1_CD phenotype_NN in_IN 9_CD of_IN these_DT pedigrees_NNS maps_NNS to_TO the_DT 
        FEOM_NNP 1_CD locus_JJ [_NN 6_CD 15_CD 25_CD 26_CD ]_NN and_CC we_PRP now_RB
        demonstrate_VBP that_IN the_DT remaining_VBG two_CD also_RB map_NN to_TO 
        FEOM_NNP 1_CD ._. Our_PRP$ analysis_NN of_IN the_DT remaining_VBG
        9_CD CFEOM_NNP 1_CD pedigrees_NNS demonstrates_VBZ that_IN 6_CD most_RBS likely_JJ result_NN
        from_IN mutations_NNS in_IN the_DT 
        FEOM_NNP 1_CD gene_NN ._. Five_CD of_IN these_DT 6_CD are_VBP
        consistent_JJ with_IN linkage_NN to_TO 
        FEOM_NNP 1_CD and_CC are_VBP either_CC not_RB linked_VBN or_CC
        not_RB consistent_JJ with_IN linkage_NN to_TO 
        FEOM_NNP 2_CD and_CC 
        FEOM_NNP 3_CD ._. One_CD is_VBZ consistent_JJ with_IN linkage_NN
        to_TO 
        FEOM_NNP 1_CD and_CC not_RB 
        FEOM_NNP 3_CD and_CC ,_, although_IN consistent_JJ with_IN
        linkage_NN to_TO 
        FEOM_NNP 2_CD ,_, ARIX_NNP mutations_NNS were_VBD not_RB
        identified_VBN ._. Therefore_RB ,_, although_IN not_RB proved_VBD ,_, the_DT CFEOM_NNP 1_CD
        phenotype_NN in_IN these_DT 6_CD families_NNS seems_VBZ likely_JJ to_TO result_VB from_IN
        mutations_NNS in_IN the_DT 
        FEOM_NNP 1_CD gene_NN ._. The_DT phenotype_NN of_IN a_DT
        seventh_JJ family_NN ,_, E_NNP ,_, is_VBZ consistent_JJ with_IN linkage_NN to_TO both_DT 
        FEOM_NNP 1_CD and_CC 
        FEOM_NNP 3_CD and_CC will_MD be_VB screened_VBD for_IN
        mutations_NNS at_IN both_DT these_DT loci_NN ._.
        In_IN contrast_NN to_TO the_DT 18_CD pedigrees_NNS whose_WP$ CFEOM_NNP 1_CD phenotype_NN
        is_VBZ consistent_JJ with_IN linkage_NN to_TO 
        FEOM_NNP 1_CD ,_, pedigree_NN BT_NNP is_VBZ not_RB linked_VBN to_TO 
        FEOM_NNP 1_CD and_CC pedigree_NN K_NNP is_VBZ inconsistent_JJ
        with_IN linkage_NN to_TO this_DT locus_JJ ._. It_PRP is_VBZ notable_JJ that_DT haplotype_NN
        analysis_NN of_IN both_DT these_DT small_JJ CFEOM_NNP 1_CD families_NNS demonstrates_VBZ
        co-inheritance_JJ with_IN the_DT 
        FEOM_NNP 3_CD locus_JJ ._. In_IN the_DT reported_VBN family_NN
        whose_WP$ autosomal_NN dominant_JJ CFEOM_NNP 3_CD phenotype_NN maps_NNS to_TO the_DT 
        FEOM_NNP 3_CD locus_JJ ,_, 9_CD of_IN the_DT 17_CD affected_VBN
        members_NNS had_VBD classic_JJ CFEOM_NNP ._. Our_PRP$ current_JJ data_NNS now_RB suggests_VBZ
        that_IN ,_, at_IN least_JJS in_IN small_JJ pedigrees_NNS ,_, CFEOM_NNP 1_CD can_MD also_RB map_VB to_TO
        the_DT 
        FEOM_NNP 3_CD locus_JJ ._. It_PRP will_MD require_VB the_DT
        identification_NN of_IN additional_JJ large_JJ CFEOM_NNP 1_CD families_NNS to_TO
        determine_VB if_IN they_PRP too_RB can_MD map_VB to_TO this_DT locus_JJ ._.
        
        ARIX_NNP ,_, which_WDT encodes_NNS a_DT transcription_NN
        factor_NN critical_JJ to_TO nIII_NN and_CC nIV_NN development_NN in_IN mice_NNS and_CC
        zebrafish_NN [_NN 22_CD 23_CD ]_NN ,_, was_VBD recently_RB identified_VBN as_IN the_DT 
        FEOM_NNP 2_CD gene_NN mutated_VBN in_IN affected_VBN
        members_NNS of_IN CFEOM_NNP 2_CD families_NNS [_NN 5_CD ]_NN ._. It_PRP was_VBD unknown_JJ ,_, however_RB ,_,
        if_IN classic_JJ CFEOM_NNP may_MD also_RB result_VB from_IN mutations_NNS in_IN this_DT
        gene_NN ._. We_PRP now_RB find_VBP that_IN we_PRP are_VBP unable_JJ to_TO identify_VB 
        ARIX_NNP mutations_NNS underlying_VBG classic_JJ
        CFEOM_NNP in_IN either_DT sporadic_JJ cases_NNS or_CC in_IN individuals_NNS from_IN
        CFEOM_NNP 1_CD families_NNS ._.
        This_DT finding_VBG is_VBZ consistent_JJ with_IN our_PRP$ prediction_NN that_IN ,_,
        compared_VBN to_TO 
        ARIX_NNP ,_, the_DT genes_NNS mutated_VBN in_IN CFEOM_NNP 1_CD may_MD
        have_VB a_DT more_RBR restricted_JJ function_NN in_IN the_DT development_NN of_IN nIII_NN
        and_CC that_IN their_PRP$ expression_NN may_MD actually_RB be_VB regulated_VBN by_IN 
        ARIX_NNP ._. This_DT prediction_NN is_VBZ based_VBN on_IN the_DT
        CFEOM_NNP 1_CD phenotype_NN and_CC on_IN the_DT neuropathological_JJ study_NN of_IN an_DT
        affected_VBN member_NN of_IN a_DT CFEOM_NNP 1_CD pedigree_NN whose_WP$ disease_NN gene_NN
        maps_NNS to_TO the_DT 
        FEOM_NNP 1_CD locus_JJ ._. This_DT study_NN revealed_VBD
        absence_NN of_IN the_DT superior_JJ division_NN of_IN the_DT oculomotor_NN nerve_NN
        and_CC the_DT corresponding_JJ central_JJ caudal_NN and_CC medial_NN nIII_NN
        subnuclei_NN ,_, and_CC marked_VBD abnormalities_NNS of_IN the_DT levator_NN
        palpebrae_NN superioris_NNS and_CC superior_JJ rectus_JJ muscles_NNS [_NN 4_CD ]_NN ._.
        These_DT findings_NNS suggest_VBP that_IN while_IN 
        ARIX_NNP is_VBZ necessary_JJ for_IN both_DT nIII_NN and_CC
        nIV_NN development_NN ,_, the_DT CFEOM_NNP 1_CD genes_NNS may_MD be_VB necessary_JJ for_IN the_DT
        development_NN of_IN only_RB these_DT two_CD specific_JJ nIII_NN subnuclei_NN ._.
      
      
        Conclusions_NNP
        The_DT genetic_JJ analysis_NN of_IN the_DT 11_CD CFEOM_NNP 1_CD pedigrees_NNS in_IN this_DT
        report_NN demonstrates_VBZ that_IN this_DT disorder_NN is_VBZ genetically_RB
        heterogeneous_JJ ._. While_IN the_DT phenotype_NN of_IN all_DT large_JJ CFEOM_NNP 1_CD
        pedigrees_NNS analyzed_VBD thus_RB far_RB map_VB to_TO the_DT 
        FEOM_NNP 1_CD locus_JJ ,_, smaller_JJR CFEOM_NNP 1_CD pedigrees_NNS
        may_MD harbor_NN mutations_NNS in_IN the_DT 
        FEOM_NNP 3_CD gene_NN ._. The_DT CFEOM_NNP 1_CD phenotype_NN does_VBZ
        not_RB ,_, however_RB ,_, appear_VB to_TO result_VB from_IN mutations_NNS in_IN 
        ARIX_NNP ._. The_DT CFEOM_NNP 1_CD families_NNS identified_VBN
        in_IN this_DT study_NN contribute_VB critical_JJ alleles_NNS toward_IN the_DT
        identification_NN of_IN the_DT mutated_VBN 
        FEOM_NNP 1_CD and_CC 
        FEOM_NNP 3_CD genes_NNS ._. Once_RB identified_VBN ,_, we_PRP
        anticipate_VBP that_IN the_DT study_NN of_IN the_DT function_NN of_IN these_DT genes_NNS
        will_MD contribute_VB to_TO our_PRP$ understanding_NN of_IN midbrain_NN motor_NN
        neuron_NN development_NN ._.
      
      
        Materials_NNS and_CC Methods_NNP
        
          Subjects_NNP
          We_PRP established_VBD inclusion_NN criteria_NNS for_IN this_DT study_NN as_IN
          follows_VBZ ._. First_LS ,_, we_PRP established_VBD criteria_NNS for_IN a_DT "_'' classic_JJ
          CFEOM_NNP individual_JJ "_'' as_IN an_DT individual_NN with_IN congenital_NN
          nonprogressive_JJ bilateral_JJ ophthalmoplegia_NN and_CC ptosis_NNS ,_, an_DT
          infraducted_JJ primary_JJ position_NN of_IN each_DT eye_NN with_IN the_DT
          inability_NN to_TO raise_VB either_CC eye_NN above_IN the_DT midline_NN ,_, and_CC
          forced_VBD duction_NN testing_NN positive_JJ for_IN restriction_NN ,_, if_IN
          testing_NN was_VBD performed_VBN ._. We_PRP then_RB established_VBD criteria_NNS for_IN a_DT
          "_'' CFEOM_NNP 1_CD pedigree_NN "_'' as_IN a_DT family_NN in_IN which_WDT every_DT affected_VBN
          member_NN met_VBD the_DT criteria_NNS for_IN "_'' classic_JJ CFEOM_NNP "_'' ._. Second_JJ ,_, we_PRP
          reviewed_VBD all_DT participants_NNS enrolled_VBD in_IN our_PRP$ ongoing_JJ CFEOM_NNP
          study_NN and_CC determined_VBN which_WDT individuals_NNS and_CC which_WDT
          pedigrees_NNS met_VBD these_DT two_CD criteria_NNS ._. For_IN a_DT pedigree_NN to_TO be_VB
          considered_VBN ,_, we_PRP required_VBD clinical_JJ examination_NN records_NNS
          and_CC /_NN or_CC photographs_NNS /_NN videos_NNS of_IN the_DT primary_JJ positions_NNS of_IN
          gaze_VBP for_IN all_DT affected_VBN study_NN participants_NNS ._. Third_NNP ,_, from_IN
          these_DT CFEOM_NNP 1_CD pedigrees_NNS we_PRP identified_VBD those_DT with_IN a_DT family_NN
          structure_NN sufficient_JJ for_IN linkage_NN analysis_NN ._. Pedigrees_NNS were_VBD
          required_VBN to_TO have_VB affected_VBN study_NN participants_NNS in_IN three_CD or_CC
          more_JJR generations_NNS ,_, or_CC affected_VBD study_NN participants_NNS in_IN two_CD
          generations_NNS with_IN at_IN least_JJS two_CD participating_VBG offspring_NN of_IN
          affected_VBN individuals_NNS ,_, or_CC two_CD or_CC more_RBR affected_JJ study_NN
          participants_NNS within_IN one_CD generation_NN ._. In_IN this_DT way_NN we_PRP did_VBD
          not_RB assume_VB a_DT mode_NN of_IN inheritance_NN ._. Lastly_NNP ,_, sporadic_JJ
          individuals_NNS with_IN classic_JJ CFEOM_NNP were_VBD screened_VBD for_IN 
          ARIX_NNP mutations_NNS ._. The_DT study_NN was_VBD
          approved_VBN by_IN the_DT Children_NNP 's_POS Hospital_NNP institutional_JJ review_NN
          board_NN ,_, and_CC all_DT study_NN participants_NNS signed_VBD informed_VBN consent_NN
          forms_NNS ._. Our_PRP$ methods_NNS adhered_VBD to_TO the_DT Declaration_NNP of_IN Helsinki_NNP
          for_IN research_NN involving_VBG human_JJ subjects_NNS ._.
        
        
          Molecular_NNP studies_NNS
          Blood_NNP samples_NNS were_VBD obtained_VBN from_IN all_DT participating_VBG
          family_NN members_NNS ,_, and_CC lymphocyte_NN DNA_NNP was_VBD extracted_VBN using_VBG
          the_DT Puregene_NNP kit_NN (_( Gentra_NNP ,_, Research_NNP Triangle_NNP Park_NNP ,_, NC_NNP )_) ._.
          Chromosome_NNP analyses_NNS of_IN GTG_NNP banded_VBN metaphase_NN cells_NNS at_IN a_DT
          400_CD band_NN level_NN minimum_JJ resolution_NN were_VBD performed_VBN on_IN one_CD
          or_CC more_RBR affected_JJ family_NN members_NNS of_IN each_DT family_NN whenever_WRB
          possible_JJ to_TO rule_VB out_IN cytogenetic_JJ abnormalities_NNS ._. All_DT
          families_NNS were_VBD analyzed_VBN for_IN linkage_NN to_TO the_DT 
          FEOM_NNP 1_CD locus_JJ ._. Families_NNS not_RB linked_VBN to_TO
          the_DT 
          FEOM_NNP 1_CD locus_JJ were_VBD also_RB analyzed_VBN for_IN
          linkage_NN to_TO the_DT 
          FEOM_NNP 2_CD and_CC 
          FEOM_NNP 3_CD loci_NN ._. Linkage_NNP studies_NNS were_VBD
          conducted_VBN using_VBG three_CD or_CC more_RBR locus_JJ specific_JJ polymorphic_JJ
          DNA_NNP micro_JJ satellite_NN markers_NNS for_IN each_DT family_NN ._. The_DT 
          FEOM_NNP 1_CD markers_NNS included_VBD 
          D_NNP 12_CD S_NNP 1648_CD ,_, D_NNP 12_CD S_NNP 61_CD ,_, D_NNP 12_CD S_NNP 1584_CD ,_, D_NNP 12_CD S_NNP 1621_CD ,_,
          D_NNP 12_CD S_NNP 345_CD ,_, D_NNP 12_CD S_NNP 59_CD ,_, D_NNP 12_CD S_NNP 2080_CD ,_, D_NNP 12_CD S_NNP 1048_CD ,_, D_NNP 12_CD S_NNP 1668_CD ,_, and_CC 
          D_NNP 12_CD S_NNP 1090_CD [_NN 6_CD 15_CD ]_NN ._. The_DT 
          FEOM_NNP 2_CD markers_NNS included_VBD 
          D_NNP 11_CD S_NNP 1337_CD ,_, D_NNP 11_CD S_NNP 4162_CD ,_, D_NNP 11_CD S_NNP 4196_CD ,_,
          D_NNP 11_CD S_NNP 1314_CD ,_, and_CC 
          D_NNP 11_CD S_NNP 1369_CD [_NN 8_CD ]_NN ._. The_DT 
          FEOM_NNP 3_CD markers_NNS included_VBD 
          D_NNP 16_CD S_NNP 539_CD ,_, D_NNP 16_CD S_NNP 3077_CD ,_, D_NNP 16_CD S_NNP 498_CD ,_, D_NNP 16_CD S_NNP 486_CD ,_,
          D_NNP 16_CD S_NNP 476_CD ,_, D_NNP 16_CD S_NNP 3063_CD ,_, D_NNP 16_CD S_NNP 689_CD ,_, D_NNP 16_CD S_NNP 2621_CD ,_, D_NNP 16_CD S_NNP 303_CD ,_, and_CC 
          D_NNP 16_CD S_NNP 3407_CD [_NN 7_CD ]_NN ._. The_DT primer_NN
          sequences_NNS for_IN these_DT polymorphisms_NNS are_VBP available_JJ from_IN the_DT
          Genome_NNP Database_NNP http_NN :_: /_NN /_NN gdbwww_NN ._. gdb_NN ._. org_NN ._. Unlabeled_NNP primers_NNS
          were_VBD purchased_VBN from_IN Genosys_NNP Biotechnologies_NNP ,_, Inc_NNP ._.
          http_NN :_: /_NN /_NN www_NN ._. genosys_NNS ._. com_NN ._. Fluorescently_NNP labeled_VBD primers_NNS
          were_VBD purchased_VBN from_IN Research_NNP Genetics_NNP ,_, Inc_NNP ._.
          http_NN :_: /_NN /_NN www_NN ._. researchgenetics_NNS ._. com_NN ._. Radioactive_NNP products_NNS
          were_VBD made_VBN by_IN 30_CD cycles_NNS of_IN PCR_NNP amplification_NN of_IN 10_CD -_: μl_NN
          reaction_NN volumes_NNS containing_VBG 10_CD -_: 30_CD ng_NN of_IN genomic_JJ DNA_NNP ,_, 40_CD
          ng_NN of_IN each_DT primer_NN ,_, 200_CD μM_NN each_DT of_IN dATP_NN ,_, dTTP_NN ,_, dGTP_NN ,_, and_CC
          dCTP_NN ,_, 1_CD μCi_NN α-_NN 32_CD P-_NNP dCTP_NN (_( 3_CD ,_, 000_CD Ci_NNP mmol_NN -_: 1_LS )_) and_CC 0_CD ._. 5_CD U_NNP Taq_NNP
          polymerase_NN (_( Perkin_NNP Elmer_NNP )_) ._. The_DT radioactively_RB labeled_VBN PCR_NNP
          products_NNS were_VBD separated_JJ on_IN 6_CD %_NN denaturing_VBG polyacrylamide_NN
          sequencing_VBG gels_NNS ,_, and_CC the_DT alleles_NNS were_VBD visualized_JJ by_IN
          autoradiography_NN [_NN 6_CD ]_NN ._. For_IN the_DT fluorescently_RB labeled_VBN
          products_NNS ,_, α-_NN 32_CD P-_NNP dCTP_NN was_VBD omitted_VBN ,_, fluorescent_NN primers_NNS
          were_VBD used_VBN ,_, and_CC the_DT products_NNS were_VBD analyzed_VBN in_IN an_DT ABI_NNP
          PrismTM_NNP 377_CD DNA_NNP Sequencer_NNP (_( Perkin_NNP Elmer_NNP )_) following_VBG the_DT
          manufacturer_NN 's_POS specifications_NNS ._.
        
        
          Lod_NNP score_NN calculations_NNS
          An_DT individual_NN was_VBD scored_VBN as_IN affected_VBN based_VBN on_IN clinical_JJ
          examination_NN records_NNS and_CC /_NN or_CC photographs_NNS of_IN primary_JJ
          position_NN of_IN gaze_VBP ._. Lod_NNP scores_NNS were_VBD calculated_VBN using_VBG the_DT
          Fastlink_NNP version_NN 3_CD ._. 0_CD package_NN of_IN programs_NNS [_NN 27_CD ]_NN ,_,
          assuming_VBG autosomal_NN dominant_JJ inheritance_NN with_IN complete_JJ
          penetrance_NN ,_, and_CC a_DT disease_NN incidence_NN of_IN 1_CD in_IN 1_CD ,_, 000_CD ,_, 000_CD
          births_NNS ,_, as_IN described_VBN previously_RB [_NN 7_CD 8_CD ]_NN ._. Because_IN of_IN the_DT
          absence_NN of_IN specific_JJ allele_NN frequencies_NNS for_IN each_DT of_IN the_DT
          ethnic_JJ groups_NNS represented_VBD in_IN the_DT study_NN ,_, we_PRP assumed_VBD ten_CD
          marker_NN alleles_NNS of_IN equal_JJ frequency_NN ._. To_TO assess_VB nonallelic_JJ
          heterogeneity_NN linkage_NN data_NNS from_IN two_CD 
          FEOM_NNP 1_CD markers_NNS spanning_VBG the_DT 
          FEOM_NNP 1_CD critical_JJ region_NN (_( 
          D_NNP 12_CD S_NNP 345_CD and_CC 
          D_NNP 12_CD S_NNP 1048_CD )_) were_VBD analyzed_VBN using_VBG a_DT
          HOMOG_NNP version_NN 3_CD ._. 35_CD program_NN [_NN 28_CD ]_NN ._.
        
        
          ARIX_NNP mutation_NN detection_NN
          
          ARIX_NNP was_VBD PCR_NNP amplified_VBN from_IN genomic_JJ
          DNA_NNP using_VBG five_CD primer_NN sets_NNS and_CC sequenced_JJ on_IN an_DT automated_VBN
          ABI_NNP 377_CD DNA_NNP seqeuncer_NN (_( PE-Applied_NNP Biosystems_NNP )_) as_IN
          described_VBN previously_RB [_NN 5_CD ]_NN ._.
        
      
    
  
